JP2012524091A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524091A5
JP2012524091A5 JP2012506099A JP2012506099A JP2012524091A5 JP 2012524091 A5 JP2012524091 A5 JP 2012524091A5 JP 2012506099 A JP2012506099 A JP 2012506099A JP 2012506099 A JP2012506099 A JP 2012506099A JP 2012524091 A5 JP2012524091 A5 JP 2012524091A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
ethyl
vida
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012506099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524091A (ja
JP5665848B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/030777 external-priority patent/WO2010120698A1/en
Publication of JP2012524091A publication Critical patent/JP2012524091A/ja
Publication of JP2012524091A5 publication Critical patent/JP2012524091A5/ja
Application granted granted Critical
Publication of JP5665848B2 publication Critical patent/JP5665848B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012506099A 2009-04-17 2010-04-12 ビタミンd受容体アゴニストとその使用 Active JP5665848B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17016009P 2009-04-17 2009-04-17
US61/170,160 2009-04-17
PCT/US2010/030777 WO2010120698A1 (en) 2009-04-17 2010-04-12 Vitamin d receptor agonists and uses thereof

Publications (3)

Publication Number Publication Date
JP2012524091A JP2012524091A (ja) 2012-10-11
JP2012524091A5 true JP2012524091A5 (cg-RX-API-DMAC7.html) 2013-05-16
JP5665848B2 JP5665848B2 (ja) 2015-02-04

Family

ID=42710758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012506099A Active JP5665848B2 (ja) 2009-04-17 2010-04-12 ビタミンd受容体アゴニストとその使用

Country Status (8)

Country Link
US (2) US20120115824A1 (cg-RX-API-DMAC7.html)
EP (1) EP2419403B1 (cg-RX-API-DMAC7.html)
JP (1) JP5665848B2 (cg-RX-API-DMAC7.html)
CN (1) CN102482210B (cg-RX-API-DMAC7.html)
AU (1) AU2010236642B2 (cg-RX-API-DMAC7.html)
CA (1) CA2758698C (cg-RX-API-DMAC7.html)
NZ (1) NZ595727A (cg-RX-API-DMAC7.html)
WO (1) WO2010120698A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993547B2 (en) * 2011-06-14 2015-03-31 Wisconsin Alumni Research Foundation 3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses
CN105456278A (zh) * 2014-09-03 2016-04-06 欣凯医药科技(上海)有限公司 一种抑制食欲的活性维生素d类似物
CN105384765A (zh) * 2014-09-04 2016-03-09 欣凯医药科技(上海)有限公司 奎宁酸内酯衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1559708A (en) * 1924-04-11 1925-11-03 Kelsey Walter Harrison Mattress and method of making the same
JP3759639B2 (ja) * 1994-04-11 2006-03-29 中外製薬株式会社 22−チアビタミン▲d3▼誘導体
JPH10182597A (ja) * 1996-10-29 1998-07-07 Sumitomo Pharmaceut Co Ltd 異性化ビタミンd誘導体
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
WO1998052574A1 (en) * 1997-05-22 1998-11-26 Cephalon, Inc. Vitamin d analogues and their neuronal effects
GB9819764D0 (en) * 1998-09-10 1998-11-04 Oxagen Limited Method
IT1311921B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
US6673782B2 (en) * 1999-04-29 2004-01-06 Wisconsin Alumni Research Foundation Treatment of systemic lupus erythematosis
US20030195175A1 (en) * 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
EP1559708A4 (en) * 2002-10-10 2006-07-19 Wisconsin Alumni Res Found 2,2-DISUBSTITUTED 1A, 25-DIHYDROXY-19-NORVITAMINE D DERIVATIVE
WO2004067504A1 (ja) * 2003-01-31 2004-08-12 Chugai Seiyaku Kabushiki Kaisha 2位置換ビタミンd誘導体
US6894037B2 (en) * 2003-07-03 2005-05-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
US20050209203A1 (en) * 2003-07-30 2005-09-22 Jin Tian Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making

Similar Documents

Publication Publication Date Title
RU2769327C2 (ru) Модуляторы интегрированного сигнального пути стресса
JP7802770B2 (ja) Jak阻害剤を調製するための方法及び中間体
AU5162690A (en) Novel benzimidazole derivatives
JP2007197460A (ja) 高コレステロール血症治療用の医薬組成物
JP2011506588A5 (cg-RX-API-DMAC7.html)
CA2852615A1 (en) Novel substituted imidazopyrimidines as gpbar1 receptor modulators
JPWO2010107115A1 (ja) グリシントランスポーター阻害物質
JPH10182583A (ja) 新規ヒドロキサム酸誘導体
JP2018535260A (ja) キナーゼ阻害剤およびその中間体の調製方法
JP7200005B2 (ja) 飽和環縮合ジヒドロピリミジノン又はジヒドロトリアジノン化合物及びその医薬用途
CN1455766A (zh) 治疗免疫疾病的新的1,2-二苯基乙烯衍生物
JP2013536798A5 (cg-RX-API-DMAC7.html)
WO2019131582A1 (ja) 含窒素6員環化合物
JP2011516523A (ja) 新規エストロゲン受容体リガンド
JPH11193273A (ja) 神経伝達物質放出増強薬としての新規な非環式アミド類
CN102448932B (zh) 氮杂环丁酮类化合物及医药应用
CN1317265C (zh) 氰基丙烯酸酯衍生物及制备方法和生物活性
KR20100087931A (ko) 로슈바스타틴의 전구체 및 그의 제조 방법
JP2022501386A (ja) ピラゾール化合物を製造する方法
CN109134432B (zh) 氘代抗抑郁药物
JP7381136B2 (ja) 高血圧症及び/又は線維症を処置するための組成物
JP6216385B2 (ja) 3,4−二置換オキサゾリジノン誘導体及びカルシウム活性化カリウムチャネルの阻害薬としてのそれらの使用
JPH02229168A (ja) ピラゾロン誘導体
JP2010529052A (ja) ジ(ヘテロ)アリールシクロヘキサン誘導体、それらの製造、それらの使用及びそれらを含む薬剤組成物
EA017306B1 (ru) Селективный агонист tr-бета 1